Showing results (451-460 of 5,035) with videos related to

Sort By:
Pageof 504
Clinical Laboratory|November 21, 2012
Prognostic prediction of BRAF(V600E) and its relationship with sodium iodide symporter in classic variant of papillary thyroid carcinomasWei Li Gao, Liu Li Wie, Ye Guo Chao, et al.
Clinical Laboratory|November 21, 2012
Differentiation of Candida dubliniensis from Candida albicans by means of MALDI-TOF mass spectrometryH Hof, U Eigner, T Maier, et al.
Clinical Laboratory|November 21, 2012
Development of microscopic review criteria by comparison urine flow cytometer, strip and manual microscopic examinationDaijun Xiang, Yulong Cong, Chengbin Wang, et al.
Clinical Laboratory|November 21, 2012
Assessment of ADVIA Centaur analyzer for the measurement of 25-OH vitamin DFernando Jesús Hermida, María Fernández, Belén Laborda, et al.
Clinical Laboratory|November 21, 2012
Effects of statin therapy on serum trace element status in dyslipidemic patients: results of a randomized placebo-controlled cross-over trialFarid Farrokhi, Mohsen Moohebati, Hamid Reza Assadzadeh Aghdaei, et al.
Clinical Laboratory|November 21, 2012
B-type natriuretic peptide not TIMI risk score predicts death after acute coronary syndromeKanit Reesukumal, Busadee Pratumvinit
Clinical Laboratory|November 21, 2012
Maternal plasma advanced glycation end products concentrations in response to oral 50-gram glucose load in mid-pregnancy: a pilot studyMichelle A Williams, Daniel A Enquobahrie, Jennifer Zimmer, et al.
Clinical Laboratory|November 21, 2012
The effect of perchlorate medication on point-of-care testingSusanne Hopf, Monika Bäumel, Michael Gruber, et al.
Clinical Laboratory|November 21, 2012
Association of fetal but not maternal P-glycoprotein C3435T polymorphism with fetal growth and birth weight, a possible risk factor for cardiovascular diseases in later lifeJian Li, Zi-Neng Wang, You-Peng Chen, et al.
Clinical Laboratory|January 8, 2013
High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen levelDominik R Weiss, Erwin F Strasser, Juergen Ringwald, et al.
Pageof 504